Recent Articles

Editorial
Convergence: Up Close and Personal
David B. Nash, MD, MBA
Read More
Clinical, Original Research
Real-World Treatment Patterns and Healthcare Costs Among Patients with FL with Early Treatment Failure of First-Line Chemoimmunotherapy
Lori A. Leslie, MD; Bruno Emond, MSc; Marie-Hélène Lafeuille, MA; Maude Vermette-Laforme, BSc; Patrick Lefebvre, MA; Qing Huang, PhD, MHS
Read More
Business, Original Research
Budget Impact of Intravenous Cetirizine Hydrochloride for the Treatment of Acute Urticaria in the Emergency Department Setting
Lisa M. Bloudek, PharmD, MS; LoAn K. Ho, PharmD; Neha Kapur, PharmD; Lonnie D. Brent, PharmD
Read More
Convergence: Up Close and Personal
David B. Nash, MD, MBA
Read More
A Sylvatic or Syncretic Approach to Healthcare Innovation?
David B. Nash, MD, MBA
Read More
A Hollywood-Style Teachable Moment
David B. Nash, MD, MBA
Read More

Most Popular Articles

Clinical, Review Article
The Quality of Care and Economic Burden of COPD in the United States: Considerations for Managing Patients and Improving Outcomes
David L. Larsen, RN, MHA; Hitesh Gandhi, MBBS; Michael Pollack, MS; Norbert Feigler, MD; Sushma Patel, PharmD; Robert A. Wise, MD
Read More
Business, Review Article
Implementation Strategies of Biosimilars in Healthcare Systems: The Path Forward
Raymond K. Cross, MD, MS; Amy L. Stewart, MSN, RN, FNP-C; Colin C. Edgerton, MD, FACP, FACR, RhMSUS; Bhavesh Shah, RPh, BCOP; John A. Welz, MPH; Jonathan Kay, MD
Read More
Editorial
A Sylvatic or Syncretic Approach to Healthcare Innovation?
David B. Nash, MD, MBA
Read More
Editorial
A Hollywood-Style Teachable Moment
David B. Nash, MD, MBA
Read More
Clinical, Review Article
Mental Illness Disclosure in the Workplace: An Opportunity for Improvement
Gary Branning, MBA; Heidi C. Waters, PhD; Christy R. Houle, PhD, MPH; Stacey L. Worthy, Esq; Betsy Fink, MBA, PMP; Katie Hayes
Read More
Editorial
A Pandemic Literary Genre
David B. Nash, MD, MBA
Read More

Web Exclusives

Conference Highlights ASCO
Trastuzumab Deruxtecan a New Standard for Patients with HER2-Low Metastatic Breast Cancer
Read More
FDA Approvals
Breyanzi Now FDA Approved for Second-Line Treatment of Large B-Cell Lymphoma
Read More
Conference Highlights ASCO
Black Patients with Cancer and COVID-19 More Likely Than White Patients to Have Therapy Disruptions
Read More
View the Latest Issue

Copyright © Engage Healthcare Communications, LLC. All rights reserved.